James P. Crowley: Newborn Vitamin K Refusal a 347% Surge in Life-Threatening Bleeding
James P. Crowley, Professor of Medicine emeritus at Brown University, shared a post on LinkedIn:
“A growing number of infants in the United States are experiencing potentially life-threatening bleeding as more parents decline a vitamin K shot that has long been recommended for newborns, according to two new studies.
One of the studies found a 347 percent increase in these bleeding cases since 2017.
For decades, the American Academy of Pediatrics has recommended that every newborn receive an injection of vitamin K, which helps blood clot and can protect against sudden and catastrophic bleeding that can occur even in otherwise healthy babies.
The injection is not a vaccine, but as mistrust in medicine has grown and as Health Secretary Robert F. Kennedy Jr. and other prominent health figures have cast doubt on the importance of childhood vaccinations, more parents have started forgoing it.”
Other posts featuring James P. Crowley on Hemostatis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian